With 330% of YTD Returns This Multibagger Stock Has A “BUY” Tag

[ad_1]

Read More/Less


The brokerage’s take on GFL

According to the research report of the brokerage “GFL is in a sweet spot with its presence in fluoropolymers, demand for which is increasingly driven by the new-age verticals of battery, solar panel and green hydrogen. GFL is in the process of expanding its capacity in fluoropolymers, which provides visibility on growth during our forecast period (FY21-FY24E). GFL is also expanding into other fluorine derivatives used in the new-age verticals, which expands the company’s addressable market and provides a vista of sustained growth. GFL has laid out a bold CAPEX plan of Rs25bn over the next three years. It is likely to see its earnings grow at 45.9% CAGR over FY21-FY24E (on a low base though), and RoCE (post-tax) improve from 6.7% to 18% over the same period. Despite the strong earnings outlook, GFL is trading at a reasonable P/E multiple of 20x FY24 vs 42.1x for Navin Fluorine and 27.5x for SRF.”

ICICI Securities has claimed that “Fluoropolymer revenues to grow at 32.9% CAGR over FY21-FY24E (58% of GFL revenues). GFL achieved full capacity utilisation in PTFE in Q2FY22 and is planning to expand capacity by 25% in FY23 with a planned CAPEX of Rs2.5bn. It already has enough capacity for R-22 and TFE; hence we expect a higher asset turnover of 1.5-1.6x. The new fluoropolymers segment has achieved only 65% capacity utilisation, and GFL expects it to hit full utilisation soon. The company is in the process of adding 57% capacity in new fluoropolymers including critical PVDF, FKM and micropowders. It is also introducing I-SAN, which finds application in flame retardants. This gives visibility on fluoropolymers’ revenue growth, while the higher contribution from this portfolio should also aid margin expansion. GFL is also backward-integrating into R-142B, which should help scale PVDF in future.”

Investment rationale

Investment rationale

The brokerage in its research report has claimed that “Gujarat Fluorochemicals (GFL), through its large portfolio of fluoropolymers, has a presence in materials which are used by new-age verticals like lithium-ion-battery, solar panels and hydrogen fuel cells. Fluoropolymers such as PVDF, PTFE and FEP would find good use in these verticals. Further, GFL is planning CAPEX targeting certain new fluorine derivatives, which could expand its addressable market in new age segments, in our view.”

The brokerage has further stated that “We believe the entry into new-age verticals puts GFL ahead of its Indian peers in high-performance materials and could prove key for the longevity of the company’s growth. Further, backward integration for most of these materials by GFL would prove to be a high entry barrier for others. Revenue contribution from the new-age verticals in our forecast period is very small, but successful execution and long-term contracts at least with India OEMs could prove to be an ice breaker, and would be key to watch.”

Buy Gujarat Fluorochemicals Limited (GFL) with a target price of Rs. 3,086 (upside 50% from CMP)

Buy Gujarat Fluorochemicals Limited (GFL) with a target price of Rs. 3,086 (upside 50% from CMP)

According to the brokerage’s call “We are initiating coverage on Gujarat Fluorochemicals with a BUY rating and target price of Rs3,086 valuing the stock at 30x FY24E EPS (P/E multiple). The 30x PE multiple is based on the market capitalisation weighted average PE multiple for other Indian fluorine companies. Our target prices imply an EV/EBITDA multiple of 18.7x FY24E.”

Disclaimer

Disclaimer

The stock has been picked from the brokerage report of ICICI Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

This Small Cap Fund Has Been Rated No 1 By Crisil, Should You Start SIP?

[ad_1]

Read More/Less


How Crisil rates small cap and other mutual funds?

Unlike most other ranking models, which are based purely on returns or net asset value (NAV), Crisil Mutual Funds Ratings uses a combination of NAV and portfolio-based attributes for evaluation. This provides a single point analysis of mutual funds, taking into consideration key parameters such as risk-adjusted returns, asset concentration, liquidity and asset quality.

While most houses that rank mutual funds can do so on sound guidelines, there is no guarantee of returns and markets being extremely volatile there is no saying where returns could be headed. In any case let’s highlight some of the things that are worth taking a look at for Kotak Small Cap Fund.

Kotak Small Cap Fund: Great performance

Kotak Small Cap Fund: Great performance

3-year returns (annualized) 5-per returns (annualized)
Kotak Small Cap Fund 34.64% 22.97%

The Kotak Small Cap Fund has assets under management to the tune of nearly Rs 6,180 crores. This fund is backed by a solid performance and has generated returns of almost 71% in the last 1-year. Having said that there is no guarantee that similar returns would be churned out in the future as well. Markets are extremely volatile and one has to be careful before investing.

The fund has holdings in stocks like Century Plyboard, Sheela Foam, Persistent Systems, Galaxy Surfactants etc. All of these stocks have rallied sharply in the last 1-year, which has boosted returns. The minimum SIP investment required is Rs 1,000.

Should you invest in the Kotak Small Cap Fund through SIP?

Should you invest in the Kotak Small Cap Fund through SIP?

It it were a lumpsum investment into a small cap fund, we would have definitely told investors to be cautious. This is because the stock markets have rallied a great deal since the covid 19 sparked a nationwide closure. In fact, indices have more than doubled in value since then. We believe that the markets are over priced and hence investors should not invest any amounts that are lumpsum. It is now more sensible to invest through the SIP route, which would be a smart strategy to adopt under the current situation. It’s also important to remember that small cap mutual funds are risky, given that the invest only in companies with a small market capitalization. Having said that we are not advising any investment in mutual funds at this stage. All we are doing is informing readers of a well-rated fund.

We are unsure of where the markets will head from here on, given the way the Omicron variant is spreading. With increasingly new variants spreading every few months, I guess the markets would have to live with covid variants for a long-time. So expect volatility and invest only if you have an appetite for risk.

Disclaimer

Disclaimer

Investing in equity mutual funds is risky and investors are advised caution. Invest only if you have an appetite to take risk. Please be informed neither Greynium Information Technologies Pvt Ltd nor the author are liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

SBI Vs HDFC Vs ICICI Vs Yes Bank: Latest Interest Rates On FDs Compared

[ad_1]

Read More/Less


ICICI Bank Fixed Deposit Interest Rates

ICICI Bank has amended its fixed deposit interest rates with effect from December 4, 2021, and following the most recent modification, the bank currently offers an interest rate of up to 5.60 percent to the general public and 6.30 percent to senior people. The bank’s adjusted interest rates on domestic, NRO, and NRE deposits of less than Rs. 2 crore are listed below.

Tenure Interest rates p.a. for regular customers Interest rates p.a. for senior citizens
7 days to 14 days 2.50% 3.00%
15 days to 29 days 2.50% 3.00%
30 days to 45 days 3.00% 3.50%
46 days to 60 days 3.00% 3.50%
61 days to 90 days 3.00% 3.50%
91 days to 120 days 3.50% 4.00%
121 days to 150 days 3.50% 4.00%
151 days to 184 days 3.50% 4.00%
185 days to 210 days 4.40% 4.90%
211 days to 270 days 4.40% 4.90%
271 days to 289 days 4.40% 4.90%
290 days to less than 1 year 4.40% 4.90%
1 year to 389 days 4.90% 5.40%
390 days to 4.90% 5.40%
15 months to 4.90% 5.40%
18 months to 2 years 5.00% 5.50%
2 years 1 day to 3 years 5.20% 5.70%
3 years 1 day to 5 years 5.40% 5.90%
5 years 1 day to 10 years 5.60% 6.30%
5 Years (80C FD) 5.40% 5.90%
W.e.f. December 04, 2021. Source: Bank Website

HDFC Bank Fixed Deposit Interest Rates

HDFC Bank Fixed Deposit Interest Rates

On December 1, 2021, HDFC Bank changed its interest rates on domestic / NRO / NRE fixed deposits of less than Rs. 2 crore. Following the most recent modification, the general public will now get a maximum interest rate of 5.50 percent on their deposits, while senior citizens will enjoy a maximum interest rate of 6.25 percent. The latest interest rates on domestic, NRO, and NRE deposits of less than Rs. 2 crore of HDFC Bank are mentioned below.

Tenor Interest Rate (per annum) Senior Citizen Rates (per annum)
7 – 14 days 2.50% 3.00%
15 – 29 days 2.50% 3.00%
30 – 45 days 3.00% 3.50%
46 – 60 days 3.00% 3.50%
61 – 90 days 3.00% 3.50%
91 days – 6 months 3.50% 4.00%
6 mnths 1 days – 9 mnths 4.40% 4.90%
9 mnths 1 day 4.40% 4.90%
1 Year 4.90% 5.40%
1 year 1 day – 2 years 5.00% 5.50%
2 years 1 day – 3 years 5.15% 5.65%
3 year 1 day- 5 years 5.35% 5.85%
5 years 1 day – 10 years 5.50% 6.25%
W.e.f. 1st December 2021. Source: Bank Website

Yes Bank Fixed Deposit Interest Rates

Yes Bank Fixed Deposit Interest Rates

On November 3rd, 2021, Yes Bank, one of India’s largest private-sector lenders, updated its fixed deposit interest rates. Yes Bank is now giving an interest rate of up to 6.25 percent to the general public and 7.00 percent to senior citizens on resident fixed deposits of less than Rs. 2 crore. The bank’s most recent fixed deposit interest rates are mentioned below.

Tenor Interest Rate (p.a.) Senior Citizen Rates (p.a.)
7 to 14 days 3.25% 3.75%
15 to 45 days 3.50% 4.00%
46 to 90 days 4.00% 4.50%
3 months to 4.50% 5.00%
6 months to 5.00% 5.50%
9 months to 5.25% 5.75%
1 Year to 6.00% 6.50%
3 Years to 6.25% 7.00%
W.e.f. 3rd November 2021. Source: Bank Website

State Bank of India (SBI) Fixed Deposit Interest Rates

State Bank of India (SBI) Fixed Deposit Interest Rates

The country’s largest lender, State Bank of India (SBI), changed its fixed deposit interest rates at the commencement of this year, and the new rates are in force from January 8, 2021. The following are the most recent interest rates on retail domestic term deposits (below Rs. 2 crore) of SBI.

Tenors Interest Rate in % (p.a.) Senior Citizen Rates in % (p.a.)
7 days to 45 days 2.9 3.4
46 days to 179 days 3.9 4.4
180 days to 210 days 4.4 4.9
211 days to less than 1 year 4.4 4.9
1 year to less than 2 year 5 5.5
2 years to less than 3 years 5.1 5.6
3 years to less than 5 years 5.3 5.8
5 years and up to 10 years 5.4 6.2
W.e.f. 08.01.2021. Source: Bank Website



[ad_2]

CLICK HERE TO APPLY

4 Small & Midcap Stocks To Buy After A 7% Fall In The Stock Market Indices

[ad_1]

Read More/Less


Aditya Birla Fashion and Retail

Emkay Global is optimistic on the stock of Aditya Birla Fashion and Retail and says the company’s performance stood out in terms of per-store recovery for Lifestyle EBOs at 110% in Q2 vs. peers at 70-80%. According to the broking firm, the faster recovery in the relatively more impacted Pantaloons segment and the strong pick-up in the wholesale channel (MBO+LFS) on festive stocking, can surprise ahead.

“Faster recovery trends, aggressive portfolio/store expansion and improving efficiencies drive our positive stance on Aditya Birla Fashion and Retail. Valuations at 27x/22x FY23/FY24E EBITDA (pre-IndAS) are at a discount to peers. We have a Buy rating on Aditya Birla Fashion and Retail with a Dec’22E target price of Rs 340, based on 30x Dec’23E pre-IndAS EBITDA. Delay in full unlocking remains a key downside risk to estimates,” the brokerage has said.

The shares of Aditya Birla Fashion and Retail last changed hands at Rs 262 on the NSE.

Bharat Forge

Bharat Forge

Emkay Global is also bullish on the stock of forgings maker, Bharat Forge, and has a buy call on this midcap stock. “Our positive view is underpinned by Bharat Forge’s leadership position in automotive forgings, focus on diversification and expected recovery in the core segments,” the brokerage has said.

According to Emkay Global, the company’s revenue growth is expected to be robust at a 19% CAGR over FY22-24E, driven by strong recovery in domestic MHCV industry production, growth in export CV segments due to a revival in North America Class-8 trucks industry; consistent growth in the PV segment and recovery in other industrial segments.

“Medium-term performance will also be aided by high-potential segments such as Defence, Railways, Aerospace and Aluminium parts. We have a buy rating on the stock with a price target of Rs 950,” the brokerage has said.

The stock of Bharat Forge was last trading at Rs 703.

Birlasoft

Birlasoft

Emkay Global also has a buy on small cap IT stock Birlasoft. The firm has set a Dec 2022 target price of Rs 550 based on 25x Dec’23E EPS.

“The management remains confident of sustaining revenue growth momentum and delivering mid-teen revenue growth in FY22 on broad-based demand, healthy deal intake (ACV remains robust although reported TCV not reflecting strength YoY), robust deal pipeline (up 50% YoY) and improving win rates, growing annuity revenue, and anticipated recovery in Enterprise Solutions. The company is well on track to achieve aspirational goal of USD1bn revenue by Mar’25 with an EBITDAM of 18%,” the brokerage has said.

Shares of Birlasoft were last changing hands at Rs 483.80.

Sunteck Realty

Sunteck Realty

The brokerage has also recommended buying the stock of small cap realty player Sunteck Realty with a Dec‘22E target price of Rs740 on the stock based on 1.2x NAV (Development NAV of Rs 618 + NAV premium of Rs 124). “Further upside is possible from faster monetization of non-core land,” the brokerage has said.

“On a trailing 3-yr moving average basis, sales may witness a 27% CAGR in FY21-FY24E. Further, we estimate core ROE improving to 11% by FY24E as both construction and sales cycle gains traction,” the brokerage has further added in its latest report.

According to Emkay the key risks include delay in JDA formation, slower than estimated execution, rapid reversal in interest rate cycle resulting in high interest rate environment.

Disclaimer

Disclaimer

The above small and midcap stocks have been picked from the latest brokerage report of Emkay Global. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

“BUY” This Mid Cap Pharma Stock With A Target Price of Rs. 2530: Edelweiss Securities

[ad_1]

Read More/Less


The brokerage’s take on Ipca Laboratories

According to the brokerage’s research report “Ipca has grown at almost 1.5x industry growth over the last five years. Its success is attributable to its R&D, where it has successfully demonstrated aceclofenac (Zerodol) superiority to other NSAIDs and low0dose chlorthalidone (CTD) efficacy that has enabled it to shift Rx to its own brands. Ipca is confident of not only sustaining its pain franchise- Zerodol peak sales >INR10bn – but also grow cardiac and other divisions. The company is getting aggressive to expand cardiac therapy to an aspirational 25% of revenue (from ~17-18%) and plans to add 350-400 salesforce.”

Edelweiss Securities Ltd in its research report has also said that “The UK business is ~60% down from its peak, but Ipca is confident of recovering a large part in the next 18 months as it will have a basket of ~25 products (up from 9) the next 18 months on its own label. The EU situation, which is currently facing excess inventory, should start easing over the next couple of quarters. Ipca’s acquisitions are either to fill gaps in existing businesses (Lyka for injectable) or part of long-term plans (Pisgah: low-volume/high-value CRAMS). Investments in subsidiaries/associates have been less than USD100mn over the last five years, keeping BS lean.”

Investment rationale

Investment rationale

The brokerage in its research report has reported that “Ipca has had a strong execution track record in the past years along with maintaining healthy balance sheet (low net D/E) despite an investment phase. Even without the US, Ipca is likely to report double-digit growth as: a) main domestic therapies pain and CVS continue to post market-leading growth; b) API exports to remain strong as Ipca bolsters sartans over its existing portfolio; and c) recovery in generics led by EU. Ipca has a moat w.r.t. cost leadership in several APIs, enabling it to be the cheapest supplier in the world. With domestic and APIs contributing ~70% to revenue, Ipca deserves to trade at a premium.”

Buy Ipca Laboratories With A Target Price of Rs. 2,530

Buy Ipca Laboratories With A Target Price of Rs. 2,530

The brokerage has stated that “The unprecedented input cost escalation should start easing over the next six months. Ipca is confident of maintaining its volume in sartans as it has developed a new process and expects orders in the rest of the API business to also pick up. Near-term pressures should not obscure its market-beating growth in India, its vertically integrated business model, API potential beyond FY22 due to capacity addition and an enviable cost optimisation track record.”

According to the brokerage’s call “Ipca has been a beneficiary of several one-offs such as HCQs during covid and sartan opportunities in API. Hence, while FY22 growth looks challenging, FY23 should see normal growth resuming. We stay optimistic on Ipca’s long-term prospects. Retain ‘BUY/SO’ with a TP of INR2,530.”

Disclaimer

Disclaimer

The stock has been picked from the brokerage report of Edelweiss Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

“BUY” This Large Cap Maharatna Stock With A Target Price of Rs. 210: Edelweiss Securities

[ad_1]

Read More/Less


The brokerage’s take on Coal India Ltd.

Edelweiss Securities in its research report has said that “CIL’s Nov-21 production/offtake rose 4.3%/10.3% YoY. Key points: i) Production rate at 1.79mt/day is the highest ever for the month of November. ii) Demand remained buoyant with the offtake rate at 1.89/day-significantly higher than in the past. iii) Pithead inventory reduced further to merely 29mt (Mar-21-end: 97mt) as demand outpaced production. iv) SECL/WCL showed a significant performance uptick while MCL continued to be the best-performing subsidiary. In our view, CIL’s performance is likely to get a leg-up from the most profitable and productive subsidiaries – MCL, SECL and NCL – ramping up production. As a result, we expect our FY22E offtake of 643mt (up 12% YoY) to be met.”

The brokerage has claimed that “We expect CIL’s cash accretion to continue mainly due to higher sales volume and e-auction prices. On the working capital front, inventory continues to decline and receivables remain under check. Hence, we expect cash accretion to sustain in H2FY22. We believe that our FY22 divided estimate of INR18/share (dividend yield: 11.3%) is likely to be met, particularly in light of the first interim dividend of INR9/share.”

Buy Coal India Ltd. with a target price of Rs. 210

Buy Coal India Ltd. with a target price of Rs. 210

According to the brokerage’s research report “Despite a rather lackluster H1FY22 performance, we expect FY22 to be salubrious for CIL mainly due to volume growth and higher e-auction prices. On the working capital front, we already see a significant respite as both receivables and inventory has declined. We believe that significant cash balance/accretion would be utilised towards the payment of dividends. We believe that the ensuing wage hike is likely to be offset by price increase of regulated coal, and be EBITDA-neutral in the worst case.”

The brokerage has further claimed that “We maintain ‘BUY/SO’ on CIL with an unchanged TP of INR210 on 9x FY23E EPS. Our recommendation is also driven by a potential dividend yield of 11-13% over the next two years.”

Disclaimer

Disclaimer

The stock has been picked from the brokerage report of Edelweiss Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

Tax department sends reassessment notices to global fund houses, BFSI News, ET BFSI

[ad_1]

Read More/Less


The Income Tax Department has reopened old assessments of at least a dozen global fund houses and private equity funds alleging under-reporting of income through the misuse of tax treaties.

The department, in a communication last week, asked these fund houses to furnish details about the structure of their business, past investors and bank signatories, an official told ET.

The department has asked them to explain irregularities in computation of income for the assessment years 2013-14, 2014-15 and 2015-16, the official said.

Its early estimates peg income that allegedly escaped assessment at more than ₹300 crore, the person said.

The notices were sent after earlier explanations by the funds were found unsatisfactory by the department, which wants to look deeper into income statements and returns. The reassessment notices were issued under Section 148 of the I-T Act, which deals with income that has escaped assessment.

Under the rules, the tax department can go back up to 10 years to scrutinise past assessments if the concealment of income is ₹50 lakh and above.

Most Investments via Mauritius, Cyprus
“Most of these global private equity funds invested in India through Mauritius and Cyprus during these assessment years,” said the official. The department wants to know why these funds hadn’t invested directly but through a particular jurisdiction, he said.

The department reserves the right to reject a tax residency certificate (TRC) if it detects abuse of tax treaty benefits and treaty shopping. The Central Board of Direct Taxes (CBDT) didn’t respond to queries.

Most global funds channelled their investments in India via jurisdictions such as Mauritius and Singapore that allowed them to enjoy capital gains tax exemption. However, India amended the tax treaty with Mauritius effective April 1, 2017, withdrawing the exemption.

Capital Gains Tax
These funds are currently subject to capital gains tax. Private equity funds, which deal in unlisted companies, attract long-term capital gains at 10%, while short-term capital gain tax is levied at 30-40%.

Foreign portfolio investors (FPIs) that invest in listed companies attract long-term capital gains at 10% for equities sold on the exchanges, even if securities transaction tax has been paid.

Tax experts said the latest move could create uncertainty for investors. “Any fresh tax demands on such old investments could create challenges for fund managers because they may not be able to recover taxes and penalties from investors who might have already exited the fund,” said Rajesh H Gandhi, partner, Deloitte Haskins & Sells LLP.

Foreign investors have been hoping that, as a result of certain favourable court cases and specific protection under the General Anti-Avoidance Rule for investments made before 2017, past investments would not be challenged, he said.



[ad_2]

CLICK HERE TO APPLY

Companies’ payments banks can’t turn into SFBs, BFSI News, ET BFSI

[ad_1]

Read More/Less


MUMBAI: Payments banks promoted by corporates will not be eligible to seek a transition to a small finance bank with the Reserve Bank of India not accepting the internal working group proposal on bank licenses for corporates.

Of the payments banks that are already licensed, Airtel Payments Bank and Jio Payments Banks are promoted by corporates. These are the only two payments banks of the 11 that were granted approval that continue to function. Aditya Birla Payments Bank had surrendered its licence in 2019 others including Sun Pharma’s Dilip Shanghvi had dropped their plans earlier.

This would mean that small finance banks would have to come from the NBFC microfinance segment or cooperative banks that choose to convert themselves into small finance banks. Most of the small finance banks operating today were largely converted from microfinance companies or non-banking finance companies engaged in small loans.

Among the non-corporate promoted payments banks, Paytm PB and Fino PB have indicated that they would pursue an SFB licence if the opportunity arises.

RBI’s internal working group on bank ownership had said that small finance banks would be considered for transitioning into a universal bank provided they meet the minimum paid-up capital and net worth requirement applicable to universal banks.

SFBs are considered to have a better business model compared to payments banks as they can lend and issue credit cards. They also do not face any geographic or size restrictions, unlike cooperative banks. However, they do face restrictions in extending large loans to corporate houses.



[ad_2]

CLICK HERE TO APPLY

Fixed Deposit That Offers 8.50% Interest With State Government Backing

[ad_1]

Read More/Less


Tamil Nadu Transport Development Finance Corporation Fixed Deposits Interest Rates (Non senior citizens, regular interest income)

Period Monthly Quarterly Annually
24 months 7.25%
36-months 7.75% 7.75% 7.98%
60-months 8.00% 8.00% 8.24%

Tamil Nadu Transport Development Finance Corporation Fixed Deposits Interest Rates (senior citizens, regular interest income)

Tamil Nadu Transport Development Finance Corporation Fixed Deposits Interest Rates (senior citizens, regular interest income)

Period Monthly Quarterly Annually
24 months 7.25%
36-months 8.25% 8.25% 8.51%
60-months 8.50% 8.50% 8.77%

The interest rates are as on December 3, 2021. This is a government of Tamil Nadu backed enterprise and hence the deposits are very safe. The deposits are also available under the cumulative scheme, where the interest rate is more or less the same, but, the yields could go higher because of compounding.

Other details of the Tamil Nadu Transport Development Finance Corporation Fixed Deposits

Other details of the Tamil Nadu Transport Development Finance Corporation Fixed Deposits

The deposits cannot be opened online and one may have to visit the office or courier the fixed deposit forms, duly filled-in with the KYC requirements. Under the money multiplier scheme the deposits are compounded quarterly. The company is a good profit making enterprise that has been generating profits since 1975.

These deposits are relatively safe, but, the only problem right now is that there is no online facility. Therefore, it would be beneficial for those staying in Tamil Nadu and who can visit the office and open the fixed deposits. For other set of investors the task maybe a little more painful.

However, with the interest rates going as high as 8.77% and if you have a big amount, even travelling to Tamil Nadu to open the deposits maybe worth.

Invest in these deposits for the long-term

Invest in these deposits for the long-term

It is unlikely that interest rates in the economy would rally higher any time soon. It is therefore imperative to block money at higher interest rates for a longer term tenure. For example, senior citizens can get as high as 8.77% on the 5-year deposit. It is therefore advisable to go for the 5 year tenure period. We believe that in an era where even the Senior Citizens Savings Scheme is able to offer only 7.4% interest for senior citizens this is not a bad option at all. Apart from this the Tamil Nadu Transport Development Finance Corporation is a wholly owned company of the government of Tamil Nadu.

There is another company called the Tamil Nadu Power and Infra Finance company, where the fixed deposit interest rate offered is as high as 8.5%. This company interestingly has online facilities and investors can open their fixed deposits online. Those who are long term investors should apply for these deposits. The Reserve Bank of India is unlikely to hike interest rates anytime soon and the current rates being offered of upto 8.5 to 8.77 per cent is not bad at all. It’s hard to get returns on fixed deposits these days.



[ad_2]

CLICK HERE TO APPLY

Market competition, lower credit offtake push banks to pursue credit growth at lower yields

[ad_1]

Read More/Less


The country’s largest lender State Bank of India (SBI) saw its yield on domestic advances fall 71 basis points on a year-on-year basis in Q2FY22 to 7.51%.

By Piyush Shukla

Yields on advances by banks have fallen between 54-166 basis points (bps) in the September quarter (Q2FY22) compared to the same period last year, due to interest rate competition from capital markets and lower credit offtake.

The country’s largest lender State Bank of India (SBI) saw its yield on domestic advances fall 71 basis points on a year-on-year basis in Q2FY22 to 7.51%. Its total domestic advances, as on September end, rose 4.6% year on year to Rs 21.56 lakh crore. ICICI Bank, on the other hand, saw its yield on advances fall to 8.34% in Q2FY22 from 8.88% a year ago. The private lender’s total loan book, as on September end stood at Rs 7.65 lakh crore, up 17.2% on year.

“Credit offtake in the system remains weak at around 6%-6.5%. On the capital markets side, the borrowing rates are very fine so some part of the borrowing is moving toward the capital market and thus banks are also passing on the benefit of lower cost of funds to borrowers and which is why you see the yield coming down,” said Karan Gupta, director – financial institutions, India Ratings and Research.

Gupta added that presently banks are not witnessing a significant impact on their net interest margins (NIMs) despite lower yields because of lower cost of funds.
For SBI, the cost of deposit has fell from 4.35% in Q2FY21 to 3.84% as on September end. Similarly, private sector banks including ICICI Bank and IDBI Bank saw their cost of deposits fall to 3.53% and 3.66% in Q2FY22 from 4.22% and 4.53% a year ago, respectively. But while not visible yet, NIMs may be impacted going ahead due to any significant increase in concerns on asset quality deterioration resulting in interest income reversals, Gupta said. In July-September, Bank of Baroda’s global NIM fell 19-bps quarter-on-quarter to 2.85% due to interest income reversal pertaining to a non-banking finance company account, as per an Edelweiss Securities report.

“…If we were to look at the net of one offs, including interest reversals on account where there was a stay, our net interest margins would be broadly unchanged between last quarter and this quarter,” said Sanjiv Chadha, MD and CEO at Bank of Baroda in a post earnings analyst call.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.



[ad_2]

CLICK HERE TO APPLY

1 5 6 7 8 9 16,282